Cryptococcosis Market

Cryptococcosis Market (Treatment - Amphotericin B (Amphocin and Fungizone), Flucytosine (Ancobon), Fluconazole (Diflucan), Voriconazole and Surgery Treatment; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Drug Store, and Mail Order Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • Rep Id : TMRGL14984
  • Published On : Feb 2017
  • No. of Pages : 166
  • Category : Pharmaceutical

1. Preface 
     1.1. Report Scope and Market Segmentation 
     1.2. Research Highlights

2. Assumptions and Research Methodology 
     2.1. Assumptions
     2.2. Acronyms Used
     2.3. Research Methodology

3. Executive Summary
     3.1. Global Cryptococcosis Market Snapshot 

4. Market Overview
     4.1. Product Overview
     4.2. Market Indicators 
     4.3. Global Cryptococcosis Market Size (US$ Mn) Forecast, 2014–2024 
     4.4. Global Cryptococcosis Market Outlook 
     4.5. Key Industry Events 
     4.6. Global Cryptococcosis Incidence Scenario-2015, by Region 
     4.7. Overview of Clinical Trials 

5. Market Dynamics
     5.1. Drivers and Restraints Snapshot Analysis
     5.2. Drivers
            5.2.1. Increasing incidence of cryptococcosis infections
            5.2.2. Rising initiatives by government and non-government organizations
            5.2.3. Impetus from HIV patients
            5.2.4. Improved access to diagnostic facilities
     5.3. Restraints
            5.3.1. High mortality among cryptococcosis infected patients
            5.3.2. Patent expiry of key drugs and entry of generics
     5.4. Opportunity Analysis
     5.5. Opportunities
            5.5.1. Setting up integrated facilities in high-potential markets
            5.5.2. Investment inflow and mergers & acquisitions

6. Global Cryptococcosis Market Analysis, by Treatment
     6.1. Introduction
     6.2. Key Findings
     6.3. Global Cryptococcosis Market Value Share Analysis, by Treatment, 2016-2024 
            6.3.1. Amphotericin B
            6.3.2. Flucytosine
            6.3.3. Fluconazole
            6.3.4. Others (Voriconazole, surgery treatment, etc.)
     6.4. Global Cryptococcosis Market Attractiveness Analysis, by Treatment, 2014–2024
     6.5. Key Trends

7. Global Cryptococcosis market Analysis, by Distribution Channel
     7.1. Introduction
     7.2. Key Findings
     7.3. Global Cryptococcosis Market Value Share Analysis, by Distribution Channel, 2016 -2024
            7.3.1. Hospital Pharmacies
            7.3.2. Retail Pharmacies
            7.3.3. Drug Store
            7.3.4. Mail Order Pharmacies
            7.3.5. Others
     7.4. Cryptococcosis Market Attractiveness Analysis, by Distribution Channel, 2014-2024
     7.5. Key Trends

8. Global Cryptococcosis Market Analysis, by Region
     8.1. Global Market Scenario by Country
     8.2. Global Cryptococcosis Market Value Share Analysis, by Region, 2016 and 2024 

9. North America Cryptococcosis Market Analysis
     9.1. Key Findings
     9.2. Market Overview
     9.3. North America Cryptococcosis Market Value Share Analysis, by Country
     9.4. North America Cryptococcosis Market Value Share Analysis, by Treatment 
     9.5. North America Cryptococcosis Market Value Share Analysis, by Distribution Channel 
     9.6. North America Cryptococcosis Market Attractiveness Analysis 
     9.7. Key Trends 

10. Middle East & Africa Cryptococcosis Market Analysis
     10.1. Key Findings
     10.2. Market Overview
     10.3. Middle East & Africa Cryptococcosis Market Value Share Analysis, by Country
     10.4. Middle East & Africa Cryptococcosis Market Value Share Analysis, by Treatment 
     10.5. Middle East & Africa Cryptococcosis Market Value Share Analysis, by Distribution Channel 
     10.6. Middle East & Africa Cryptococcosis Market Attractiveness Analysis 
     10.7. Key Trends 

11. Asia Pacific Cryptococcosis Market Analysis
     11.1. Key Findings
     11.2. Asia Pacific Cryptococcosis Market Overview
     11.3. Asia Pacific Cryptococcosis Market Value Share Analysis, by Country 
     11.4. Asia Pacific Cryptococcosis Market Value Share Analysis, by Treatment 
     11.5. Asia Pacific Cryptococcosis Market Value Share Analysis, by Distribution Channel
     11.6. Asia Pacific Cryptococcosis Market Attractiveness Analysis 
     11.7. Key Trends

12. Europe Cryptococcosis market Analysis
     12.1. Key Findings
     12.2. Market Overview
     12.3. Europe Cryptococcosis Market Value Share Analysis, by Country
     12.4. Europe Cryptococcosis Market Value Share Analysis, by Treatment 
     12.5. Europe Cryptococcosis Market Value Share Analysis, by Distribution Channel 
     12.6. Europe Cryptococcosis Market Attractiveness Analysis 
     12.7. Key Trends 

13.  Latin America Cryptococcosis market Analysis
     13.1. Key Findings
     13.2. Market Overview     
     13.3. Latin America Cryptococcosis Market Value Share Analysis, by Country
     13.4. Latin America Cryptococcosis Market Value Share Analysis, by Treatment 
     13.5. Latin America Cryptococcosis Market Value Share Analysis, by Distribution Channel 
     13.6. Latin America Cryptococcosis Market Attractiveness Analysis 
     13.7. Key Trends 

14. Competition Landscape
     14.1. Cryptococcosis Market Share Analysis By Company, 2016 (Estimated)
     14.2. Competition Matrix
     14.3. Company Profiles
            14.3.1. Bristol-Myers Squibb Company
                      14.3.1.1. Company Details
                      14.3.1.2. Business Overview
                      14.3.1.3. Financial Overview
                      14.3.1.4. Strategic Overview
                      14.3.1.5. SWOT Analysis
            14.3.2. Janssen Biotech, Inc. (Johnson & Johnson)
                      14.3.2.1. Company Details
                      14.3.2.2. Business Overview
                      14.3.2.3. Financial Overview
                      14.3.2.4. Strategic Overview
                      14.3.2.5. SWOT Analysis
            14.3.3. Abbott Laboratories
                      14.3.3.1. Company Details
                      14.3.3.2. Business Overview
                      14.3.3.3. Financial Overview
                      14.3.3.4. Strategic Overview
                      14.3.3.5. SWOT Analysis
            14.3.4. Novartis AG
                      14.3.4.1. Company Details
                      14.3.4.2. Business Overview
                      14.3.4.3. Financial Overview
                      14.3.4.4. Strategic Overview
                      14.3.4.5. SWOT Analysis
            14.3.5. Pfizer, Inc.
                      14.3.5.1. Company Details
                      14.3.5.2. Business Overview
                      14.3.5.3. Financial Overview
                      14.3.5.4. Strategic Overview
                      14.3.5.5. SWOT Analysis
            14.3.6. Valeant Pharmaceuticals, Inc.
                      14.3.6.1. Company Details
                      14.3.6.2. Business Overview
                      14.3.6.3. Financial Overview
                      14.3.6.4. Strategic Overview
                      14.3.6.5. SWOT Analysis
            14.3.7. Glenmark Pharmaceuticals
                      14.3.7.1. Company Details
                      14.3.7.2. Business Overview
                      14.3.7.3. Financial Overview
                      14.3.7.4. Strategic Overview
                      14.3.7.5. SWOT Analysis
            14.3.8. Viamet Pharmaceuticals, Inc.
                      14.3.8.1. Company Details
                      14.3.8.2. Business Overview
                      14.3.8.3. Financial Overview
                      14.3.8.4. Strategic Overview
                      14.3.8.5. SWOT Analysis
            14.3.9. Sigmapharm Laboratories LLC
                      14.3.9.1. Company Details
                      14.3.9.2. Business Overview
                      14.3.9.3. Financial Overview
                      14.3.9.4. Strategic Overview
                      14.3.9.5. SWOT Analysis

List of Tables

TABLE 1 Overview of major clinical trials for Cryptococcosis Treatment
TABLE 2 Global Cryptococcosis Market Size (US$ Mn) Forecast, by Treatment, 2014–2024
TABLE 3 Global Cryptococcosis Market Size (US$ Mn) Forecast, by Amphotericin B Treatment, 2014–2024
TABLE 4 Global Cryptococcosis Market Size (US$ Mn) Forecast, by Flucytosine Treatment, 2014–2024
TABLE 5 Global Cryptococcosis Market Size (US$ Mn) Forecast, by Fluconazole Treatment, 2014–2024
TABLE 6 Global Cryptococcosis Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
TABLE 7 Global Cryptococcosis Market Size (US$ Mn) Forecast, by Region, 2014–2024
TABLE 8 North America Cryptococcosis Market Size (US$ Mn) Forecast, by Country, 2014–2024
TABLE 9 North America Cryptococcosis Market Size (US$ Mn) Forecast, by Treatment, 2014–2024
TABLE 10 North America Cryptococcosis Market Size (US$ Mn) Forecast, by Amphotericin B Treatment, 2014–2024
TABLE 11 North America Cryptococcosis Market Size (US$ Mn) Forecast, by Flucytosine Treatment, 2014–2024
TABLE 12 North America Cryptococcosis Market Size (US$ Mn) Forecast, by Fluconazole Treatment, 2014–2024
TABLE 13 North America Cryptococcosis Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
TABLE 14 Middle East & Africa Cryptococcosis Market Size (US$ Mn) Forecast, by Country/Region, 2014–2024
TABLE 15 Middle East & Africa Cryptococcosis Market Size (US$ Mn) Forecast, by Treatment, 2014–2024
TABLE 16 Middle East & Africa Cryptococcosis Market Size (US$ Mn) Forecast, by Amphotericin B Treatment, 2014–2024
TABLE 17 Middle East & Africa Cryptococcosis Market Size (US$ Mn) Forecast, by Flucytosine Treatment, 2014–2024
TABLE 18 Middle East & Africa Cryptococcosis Market Size (US$ Mn) Forecast, by Fluconazole Treatment, 2014–2024
TABLE 19 Middle East & Africa Cryptococcosis Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
TABLE 20 Asia Pacific Cryptococcosis Market Size (US$ Mn) Forecast, by Country/Region, 2014–2024
TABLE 21 Asia Pacific Cryptococcosis Market Size (US$ Mn) Forecast, by Treatment, 2014–2024
TABLE 22 Asia Pacific Cryptococcosis Market Size (US$ Mn) Forecast, by Amphotericin B Treatment, 2014–2024
TABLE 23 Asia Pacific Cryptococcosis Market Size (US$ Mn) Forecast, by Flucytosine Treatment, 2014–2024
TABLE 24 Asia Pacific Cryptococcosis Market Size (US$ Mn) Forecast, by Fluconazole Treatment, 2014–2024
TABLE 25 Asia Pacific Cryptococcosis Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
TABLE 26 Europe Cryptococcosis Market Size (US$ Mn) Forecast, by Country/Region, 2014–2024
TABLE 27 Europe Cryptococcosis Market Size (US$ Mn) Forecast, by Treatment, 2014–2024
TABLE 28 Europe Cryptococcosis Market Size (US$ Mn) Forecast, by Amphotericin B Treatment, 2014–2024
TABLE 29 Europe Cryptococcosis Market Size (US$ Mn) Forecast, by Flucytosine Treatment, 2014–2024
TABLE 30 Europe Cryptococcosis Market Size (US$ Mn) Forecast, by Fluconazole Treatment, 2014–2024
TABLE 31 Europe Cryptococcosis Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
TABLE 32 Latin America Cryptococcosis Market Size (US$ Mn) Forecast, by Country, 2014–2024
TABLE 33 Latin America Cryptococcosis Market Size (US$ Mn) Forecast, by Treatment, 2014–2024
TABLE 34 Latin America Cryptococcosis Market Size (US$ Mn) Forecast, by Amphotericin B (Treatment), 2014–2024
TABLE 35 Latin America Cryptococcosis Market Size (US$ Mn) Forecast, by Flucytosine (Treatment), 2014–2024
TABLE 36 Latin America Cryptococcosis Market Size (US$ Mn) Forecast, by Fluconazole (Treatment), 2014–2024
TABLE 37 Latin America Cryptococcosis Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024

List of Figures

FIG. 1 Global Cryptococcosis Market Size (US$ Mn) Forecast, 2014–2024
FIG. 2 Market Value Share By Region (2016)
FIG. 3 Market Value Share By Treatment (2016)
FIG. 4 Market Value Share By Distribution Channel (2016)
FIG. 5 Global Cryptococcosis Market Value Share Analysis, by Treatment, 2016 and 2024
FIG. 6 Global Cryptococcosis Market - Amphotericin B Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
FIG. 7 Global Cryptococcosis Market - Flucytosine Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
FIG. 8 Global Cryptococcosis Market - Fluconazole Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
FIG. 9 Global Cryptococcosis Market - Others Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
FIG. 10 Cryptococcosis Market Attractiveness Analysis, by Treatment, 2016–2024
FIG. 11 Global Cryptococcosis Market Value Share Analysis, by Distribution Channel, 2016 and 2024
FIG. 12 Global Cryptococcosis Market - Hospital Pharmacies Revenue and Y-o-Y Growth (%), 2014–2024
FIG. 13 Global Cryptococcosis Market - Retail Pharmacies Revenue and Y-o-Y Growth (%), 2014–2024
FIG. 14 Global Cryptococcosis Market - Drug Store Revenue and Y-o-Y Growth (%), 2014–2024
FIG. 15 Global Cryptococcosis Market - Drug Store Revenue and Y-o-Y Growth (%), 2014–2024
FIG. 16 Global Cryptococcosis Market - Mail Order Pharmacies Revenue and Y-o-Y Growth (%), 2014–2024
FIG. 17 Global Cryptococcosis Market - Other Distribution Channels Revenue and Y-o-Y Growth (%), 2014–2024
FIG. 18 Global Cryptococcosis Market Attractiveness Analysis, by Distribution Channel, 2016–2024
FIG. 19 Global Cryptococcosis Market Value Share Analysis, by Region, 2016 and 2024
FIG. 20 Global Cryptococcosis Market Attractiveness Analysis, by Region, 2014–2024
FIG. 21 North America Cryptococcosis Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2014–2024
FIG. 22 North America Cryptococcosis Market Attractiveness Analysis, by Country, 2016–2024
FIG. 23 North America Cryptococcosis Market Value Share Analysis, by Country, 2016 and 2024
FIG. 24 North America Cryptococcosis Market Value Share Analysis, by Treatment, 2016 and 2024
FIG. 25 North America Cryptococcosis Market Value Share Analysis, by Distribution Channel, 2016 and 2024
FIG. 26 North America Market Attractiveness Analysis, by Treatment, 2014–2024
FIG. 27 North America Market Attractiveness Analysis, by Distribution Channel, 2014–2024
FIG. 28 Middle East & Africa Cryptococcosis Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2014–2024
FIG. 29 Middle East & Africa Cryptococcosis Market Attractiveness Analysis, by Country/Region, 2016–2024
FIG. 30 Middle East & Africa Cryptococcosis Market Value Share Analysis, by Country/Region, 2016 and 2024
FIG. 31 Middle East & Africa Cryptococcosis Market Value Share Analysis, by Treatment, 2016 and 2024
FIG. 32 Middle East & Africa Cryptococcosis Market Value Share Analysis, by Distribution Channel, 2016 and 2024
FIG. 33 Middle East & Africa Market Attractiveness Analysis, by Treatment, 2014–2024
FIG. 34 Middle East & Africa Market Attractiveness Analysis, by Distribution Channel, 2014–2024
FIG. 35 Asia Pacific Cryptococcosis Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2014–2024
FIG. 36 Asia Pacific Cryptococcosis Market Attractiveness Analysis, by Country/Region, 2016–2024
FIG. 37 Asia Pacific Cryptococcosis Market Value Share Analysis, by Country/Region, 2016 and 2024
FIG. 38 Asia Pacific Cryptococcosis Market Value Share Analysis, by Treatment, 2016 and 2024
FIG. 39 Asia Pacific Cryptococcosis Market Value Share Analysis, by Distribution Channel, 2016 and 2024
FIG. 40 Asia Pacific Market Attractiveness Analysis, by Treatment, 2016–2024
FIG. 41 Asia Pacific Market Attractiveness Analysis, by Distribution Channel, 2016–2024
FIG. 42 Europe Cryptococcosis Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2014–2024
FIG. 43 Europe Cryptococcosis Market Attractiveness Analysis, by Country/Region, 2016–2024
FIG. 44 Europe Cryptococcosis Market Value Share Analysis, by Country/Region, 2016 and 2024
FIG. 45 Europe Cryptococcosis Market Value Share Analysis, by Treatment, 2016 and 2024
FIG. 46 Europe Cryptococcosis Market Value Share Analysis, by Distribution Channel, 2016 and 2024
FIG. 47 Europe Market Attractiveness Analysis, by Treatment, 2014–2024
FIG. 48 Europe Market Attractiveness Analysis, by Distribution Channel, 2014–2024
FIG. 49 Latin America Cryptococcosis Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2014–2024
FIG. 50 Latin America Cryptococcosis Market Attractiveness Analysis, by Country, 2016–2024
FIG. 51 Latin America Cryptococcosis Market Value Share Analysis, by Country, 2016 and 2024
FIG. 52 Latin America Cryptococcosis Market Value Share Analysis, by Treatment, 2016 and 2024
FIG. 53 Latin America Cryptococcosis Market Value Share Analysis, by Distribution Channel, 2016 and 2024
FIG. 54 Latin America Market Attractiveness Analysis, by Treatment, 2016–2024
FIG. 55 Latin America Market Attractiveness Analysis, by Distribution Channel, 2016–2024
FIG. 56 Global Cryptococcosis Market Share Analysis, by Company, 2016 (Estimated)